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ABSTRACT
Generation of an optimal immune response against a pathogen leads to protection 
from disease. Cytokines orchestrates a complex but well coordinated interaction 
between the cells of the immune system. Precise and sequential signals are required 
for the induction of a particular cellular function. In this study, I have analyzed the 
minimal signal requirement for memory cytotoxic T lymphocyte (mCTL) effector 
function. I have used human peripheral blood T cells as the source of influenza virus 
specific mCTL precursors, and influenza virus infected and formaldehyde fixed cells 
as antigen presenters in our assay system. Using this model, we have identified an 
essential requirement for antigenic restimulation in influenza virus specific mCTL 
induction. Further I show here, using known recombinant cytokines, that IL-4, IL-7, 
IL-10 and IL-12 can function as CTL differentiation factors. Unlike many previous 
reports, in our assay system, we did not find any direct cytotoxicity induction by IL- 
2, but it has modulatory role on IL-7, IL-10 and IL-12 mediated induction of 
cytotoxicity. In contrast to IL-2, IL-4 has both positive and negative regulatory 
effects on cytotoxicity induction and depends critically on the time of addition of 
cytokines after antigen encounter.
x
Chapter 1 
INTRODUCTION
Significance
The immune system has evolved multiple mechanisms to efficiently neutralize a 
panoply of pathogenic agents, from simple intracellular pathogens like viruses to 
large metacellular parasites. Despite these elaborate immune mechanisms, many 
pathogens enter the host and cause disease. Understanding the mechanisms of 
immunity may lead to the development of better prophylactic and treatment 
procedures.
Classical vaccine strategies that are designed to induce antibodies are ineffective 
in conferring protection against many pathogens because the surface proteins of these 
pathogens, against which protective antibodies are directed, undergo antigenic 
variation (Clerici et al., 1991). Human influenza virus is one of the most common 
pathogens which uses this mechanism to evade the humoral immune system. By 
contrast, influenza virus-specific cytotoxic T lymphocytes (CTL) have been shown to 
recognize viral proteins which do not exhibit such antigenic variation. Such CTLs 
have been implicated in the recovery from natural influenza virus infections (Mitchell 
et al., 1985; McMichael et al., 1983) and the induction of memory CTL (mCTL) is 
thought to be necessary for long term protection. The generation of the CTL response 
is in turn dependent upon the presence of various accessory signals, some of which 
are mediated by cytokines. Therefore, one approach to future vaccine strategies for
1
influenza should include stimulation of long-lasting mCTL responses, possibly by 
using the right combination of cytokines as adjuvants.
In this study I have analyzed the minimal signal requirement for mCTL induction 
and the modulatory effect of eight known cytokines. These cytokines were used 
because of their reported biological effects on T cells and their ready availability as 
recombinant products. Of all the cytokines tested, EL-7, IL-10 and IL-12 were found 
to have significant effects on mCTL induction. Each was further characterized for its 
dose and time dependence, and the specificity of induced cytotoxic activity. Some of 
these cytokines may have a potential in immunotherapy, not only in influenza but 
also in other diseases like AIDS. The identification and characterization of cytokines 
involved in mCTL induction using in vitro assays may provide the framework for 
further testing in animal models and eventually, humans.
Literature Review
Influenza virus is a member of the genus orthomyxovirus characterized by a 
negative stranded RNA genome surrounded by a lipid bilayer envelope. Eight single 
stranded RNA molecules in each virion encode a total of 10 proteins. Influenza virus 
exists as three biologically similar, but antigenically and epidemiologically 
heterologous types; A, B, and C (Murphy and Webster, 1989). Influenza is an 
important pathogen of humans, swine, horses and birds. Except in birds, the main 
disease symptoms relate to the infection of the respiratory tract. Acute inflammation 
of the larynx, trachea and bronchi are observed with inflammation and edema. The
3incubation period can vary from one to four days depending on the immune status of 
the host. Onset of illness is abrupt with the occurrence of headache, chills, dry cough 
followed by fever, myalgia, malaise and anorexia. Fever disappears within a week, 
while cough and weakness can persist for 2-3 weeks. In humans, infection with 
influenza A virus is common and causes an appreciable annual mortality (Gregg et 
al., 1978). There is also a persistent threat of a pandemic with high death rate, such 
as occurred in 1919, 1957 and 1968 (Kaplan and Webster, 1977).
Inflection with influenza A virus generates antibodies to hemagglutinin (HA), 
neuraminidase (NA), nucleoprotein (NP) and matrix (M) proteins. Antibodies to HA 
and NA glycoproteins are associated with resistance to infection whereas antibodies 
to NP and M are not (Murphy and Webster, 1989). Despite the presence of 
neutralizing antibodies, humoral immunity is poorly effective in the long term 
because of the appearance of mutant virus strains and subtypes that evade 
neutralizing effects of specific antibody (Murphy and Webster, 1989). The escape 
from neutralization is the result of changes in the surface glycoproteins, HA and NA. 
These virus variants arise as the result of the accumulation of point mutations in the 
HA and NA genes leading to changes in surface antigenic structure. Thus, despite the 
presence of neutralizing antibodies to the prevalent virus strain, the human 
populations are susceptible to influenza by the newly derived virus strains. This type 
of virus variation which is driven by antibodies and gives rise to a new virus strain 
every few years is called antigenic drift. Every 10-30 years there is a major change 
in the HA and/or NA subtype which results either from the selection of a new
recombinant virus from an animal reservoir or from recycling of an earlier human 
strain. This type of antigenic variation, due to recombination between strains, is 
called antigenic shift and is responsible for widespread outbreaks of influenza 
infection even amongst vaccinated populations (Murphy and Webster). Therefore, 
vaccines that boost antibody immunity are of limited value.
Since cross-protective immunity does occur after natural infections (Hoskins et 
al., 1979) it appears likely that other arms of the immune system may be involved. 
There are several lines of evidence indicating a role for cell mediated immune (CMI) 
responses in recovery from influenza virus infections. Adoptive transfer of spleen 
cells with high levels of cytotoxic activity was found to promote recovery from 
influenzal pneumonia in mice (Yap et al., 1978). In contrast, transfer of spleen cells 
which enhanced antibody responses, but were not cytotoxic, did not affect recovery. 
In humans evidence for a protective role is indirect. Thus, the level of influenza 
virus-specific CTL activity inducible in lymphocyte cultures may be correlated with 
the rapidity of recovery from influenza virus infection (McMichael et al., 1981). 
Similarly, the duration of virus shedding in vivo is inversely correlated with 
cytotoxic activity measured in vitro (McMichael et al., 1992). Finally, inability to 
generate an influenza virus specific mCTL response in vitro is associated with an 
increased susceptibility to influenza infection (McMichael et al., 1977). Taken 
together, all these results indicate a central role for CMI responses, and in particular 
CTL generation, in protection from influenzal disease.
CTLs are a major subpopulation of T lymphocytes which expresses the CD8+ 
glycoprotein and recognize foreign antigen presented by class I molecules of the 
major histocompatibility complex (MHC) (Townsend et al., 1986). They were first 
recognized in vitro as vigorous responders to allogeneic MHC molecules (Cerottini 
and Brunner, 1974) and then as cells that could lyse virus infected target cells 
(Gardner et al., 1974). Specificity studies on virus specific CTL responses led to the 
discovery of MHC restriction (Zinkemagel and Doherty, 1979). Later it was shown 
that CTLs recognize peptide fragments of viral antigens presented by class I MHC 
molecules (Townsend et al., 1985; Townsend et al., 1986). CTLs have been shown to 
play a central protective role in a variety of virus infections, including influenza.
The majority of influenza virus specific CTLs are cross reactive between 
subtypes of influenza A (McMichael et al., 1977; McMichael et al., 1981). Initially it 
was thought that, like antibodies, CTLs are generated only against surface 
glycoproteins. Then came the discovery that some murine CTLs apparently recognize 
influenza A virus nonglycoproteins (Braciale and Yap, 1978). These non surface, 
nonglycoproteins include the polymerase (Bennink et al., 1982), NP (Townsend and 
Skehel, 1982; Towensend et a l ,  1985) and M protein (Yewdell et al., 1985). Further 
characterization of NP-specific CTL identified two distinct epitopes on the NP 
molecule recognized by CTL, (Townsend et al., 1985). It has been shown that such 
CTL provide cross protection from lethal influenza virus infection when adoptively 
transferred to mice (Taylor and Askonas, 1986; Kuwano et al., 1990). Similarly, 
immunization of mice with internal viral proteins can also protect mice from lethal
virus challenge (Wraith and Askonas, 1985). Recently, the novel approach of ’gene 
vaccine’, injecting naked DNA containing the coding sequence for influenza 
nucleoprotein into mice, induced mCTL and was protective (Ulmer et al., 1993).
Thus it is clear that future vaccine strategies to influenza should include methods to 
boost mCTL responses and maintain a sustained mCTL pool.
While infection with influenza virus leads to the generation of a CTL response 
which is cross-reactive, it fails to provide life-long protection. McMichael and 
coworkers (1982) found a marked decline in influenza virus specific mCTL activity 
in human volunteers between 1977 and 1982. They determined the half life of mCTL 
after natural infection was between 2-3 years, and less than twelve months after 
vaccination. By contrast, Horohov et al. (1988a) found persistent levels of mCTL to 
influenza in the peripheral blood of healthy adult volunteers. They determined the 
frequency of influenza virus specific mCTL precursors to be about 1 in 20,000 
peripheral T cells of normal human adult volunteers. Similar precursor frequencies 
for mCTL have been reported for varicella zoster (Hickling et al., 1987) and 
cytomegalovirus (Borysiewicz et al., 1988a, 1988b). Somewhat higher frequencies 
were reported for herpes simplex virus (HSV) (Schmid, 1988) and for mumps virus 
(Enssle et al., 1987). Thus it appears that mCTL exist in the peripheral blood longer 
than previously perceived. These results fail to account for the decline in mCTL 
activity as reported by McMichael and coworkers (1982).
In general, mCTL frequencies do not appear to correlate with the level of 
cytotoxicity generated in bulk lymphocyte cultures. One explanation for the
phenomenon is that there is variation in accessory cell function required for mCTL 
induction resulting in an apparent decline in mCTL activity. This may be due to 
progressive decline with time in activity of antigen specific memory helper T 
lymphocytes (mHTL). In corroboration with this hypothesis, many reports indicate 
that class II restricted HTL are required for the induction of primary (Friedman et al., 
1981) and memory (Braakman et al., 1986; Palladino et al., 1992) class I restricted 
CTL. However, there is some controversy in this area, Gomez et al. (1989) reported 
an essential requirement for CD4+ cells in influenza virus specific CD8+ CTL 
induction, but not for EBV specific CD8+ CTL induction. Similarly Jennings et al. 
(1991) reported an essential requirement for CD4+ cells in HSV specific primary 
CTL induction but not mCTL induction and they postulated a role for CD8+ HTL in 
mCTL induction. Using Male H-Y antigen as the stimulating antigen, Gray and 
Matzinger, (1991) reported that long term maintenance of mCTL may depend on 
mHTL and absence of antigen may lead to CTL memory loss. Palladino et al. (1992) 
reported that helper cells were required for influenza virus specific mCTL induction 
from primed mice, further they showed that the helper cells could be replaced by IL- 
2 or IL-4. While it seems likely that the role of HTL is to provide the required 
soluble cofactors for the antigen stimulated CTL to undergo proliferation and 
differentiation (Finke et al., 1981; Heeg et al., 1987), questions remain regarding the 
minimal requirements for mCTL generation.
Since T cell activation requires multiple signals and depends on the stage of 
maturation of the cells, it has been proposed that memory cells have a less stringent
activation requirement than naive cells. Differences in requirements for proliferation 
and cytotoxicity among naive and memory cells have been reported. For example, 
memory cells can be induced to proliferate with a combination of antibodies to CD2 
whereas naive cells also require monocyte derived factors (Kasahara et al., 1990). 
Similarly, memory CD8+ human peripheral blood T cells proliferated better than 
naive cells when stimulated with antigen and IL-7 (Welch et al., 1989). It has been 
proposed that mCTL only require restimulation with IL-2 in order to generate 
cytolytic activity (Yoshimoto et al., 1985). It has also been suggested that the 
memory cells represent those CTL precursors which had been activated and had 
proliferated but not yet differentiated into mature cytolytic effector cells (Owen et al., 
1988). Other results indicate a similarity in activation requirements for memory and 
primary CTL. Gray and Matzinger, (1991) determined that mCTL induction requires 
restimulation with antigen and both primary (Keene et al., 1992; Pilarski, 1977; 
Tucker et al., 1982) and memory CTL (Guerder and Matzinger, 1989) depend on two 
signals for activation. The first signal is delivered through the interaction of the T 
cell receptor with antigen-MHC complex on an antigen presenting cell (APC) and the 
second, nonspecific signal, derived from accessory cells (Janeway, 1989; Bretscher, 
1992). Signal two might involve a membrane-membrane interaction or a short range 
soluble molecule (Bretcher, 1992).
The preceding discussion demonstrates that our knowledge about the mechanism 
of mCTL induction is inconclusive. While it is apparent the mCTL induction is 
dependent upon accessory cells, the precise requirements are unknown. It is apparent
9that many of these interactions involve various cytokines. Over the past decade more 
than 30 different cytokines have been identified and characterized, many of which 
have multiple effects on T cells. Only a few of these have been studied for their 
ability to induce mCTL. An overview of the T cell effects of the eight cytokines 
used in this study is given below.
Originally designated as lymphocyte activating factor (LAF) (Gery et al., 1974), 
IL-1 is a soluble protein present in the macrophage culture supernatants which 
stimulated the growth of accessory cell depleted T cells. Subsequently it was found 
that IL-1 functioned by potentiating T cell production of IL-2 (Larsson et al., 1980; 
Smith et al., 1980). Klarnet et al. (1989) reported that helper independent CD8+ 
cytotoxic cells express IL-1 receptor (IL-1R), proliferate in response to IL-1, and 
produce IL-2 after antigen stimulation, whereas IL-2 nonproducing CD8+ cells do 
not express IL-1R. Uyttenhove et al. (1988) found IL-1 mediated proliferation of 
PHA stimulated murine thymocytes, whereas other reports indicated a lack of any 
proliferative activity for IL-1 on PHA stimulated human T cells (Ceuppens et al., 
1988; Kuhweide et al., 1990). Holsti et al. (1989) using highly purified CD4+ cells 
stimulated with antiTCR or antiCD3, found that IL-1 and IL-6 together augmented 
CD4+ proliferation, IL-1 alone had no effect. Suda et al., (1990) found that IL-1 
augments IL-2 and IL-4 induced T cell proliferation. Thus whether IL-1 alone can 
provide a proliferative signal still remains controversial.
Farrar et al. (1979) reported an early role for IL-1 in alloantigen specific CTL 
induction. IL-1 produced by macrophages induces IL-2 and IFN-y production by T
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cells, IFN-y being the signal for cells to become cytotoxic. Mizuochi et al. (1989) 
reported the ability of IL-1 to directly induce CTL activity from CD8+ cells. Renauld 
et al. (1989) showed that the combination of IL-1 and IL-6 caused CTL induction 
from human and murine T cells after alloantigen stimulation, either one alone having 
no effect. A role for IL-1 in influenza virus-specific CTL induction has not yet been 
determined.
IL-2 shows a strong mitogenic activity on antigen stimulated T-cells (Kasakura, 
1965). Gillis et al. (1978) identified T cells as both the producers of and responder to 
IL-2 and designated it as T cell growth factor (TCGF). While resting peripheral T 
cells neither produce nor respond to IL-2, activation through the T cell receptor make 
them responsive to IL-2 (Cantrell et al., 1983). Since IL-2 alone is sufficient for 
the induction of murine alloantigen specific mCTL (Yoshimoto et al., 1985; Erard et 
al., 1985), murine influenza virus specific mCTL (Palladino et al., 1991) and human 
influenza virus specific mCTL (Braakman et al., 1986; Fishwild et al., 1988), it was 
postulated that IL-2 directly acts on mCTL to induce cytotoxicity. Since most of 
these studies involved bulk cultures of CD8+ cells, endogenous cytokines could be 
providing the cofactor activity for mCTL induction (Andrus et al., 1984). Likewise, 
the irradiated or mitomycin-c treated stimulator cells could also be producing 
unknown soluble factors. In support of this observation, Takai et al. (1986) found a 
requirement for supernates from concanavalin-A (Con-A) stimulated spleen cells in 
the induction of CTL from murine thymocytes. Bertagnolli et al. (1991) found that
CTL induction from Con-A stimulated CD8+ murine thymocytes required both IL-2 
and IL-6, either one alone being insufficient.
Widmer et al. (1987) first reported primary and secondary CD8+ CTL induction 
by IL-4 using mixed lymphocyte cultures of murine splenocytes, IL-4 appeared to be 
a better CTL inducer than IL-2. The observed activity could be due to other 
endogenously produced factors, since the stimulator cells used were irradiated and 
contained cells other than T  cells. Palladino et al. (1991) found that induction of 
influenza virus specific, CD8+ mCTL requires a factor derived from type 2 T helper 
cell clones which was identified as IL-4. IL-4 induction of CD8+ CTL from Con-A 
stimulated murine thymocytes requires endogenously produced IL-2 and IL-6 
(Bertagnolli et al., 1991). IL-4 appears to stimulate the production of endogenous IL- 
2 production from thymocytes. Trenn et al. (1988) observed CTL and serine esterase 
induction by IL-4 but not IL-2, using phorbol myristate acetate (PMA) treated or 
anti-T cell receptor (TCR) antibody stimulated small resting T cells and CD8+ cells. 
Horohov et al. (1988b) reported IL-4 mediated influenza virus specific mCTL 
induction when added late in culture.
Horohov et al. (1988b) first reported the early inhibitory effect of IL-4 on 
antigen specific CTL induction. Similarly Palladino et al. (1991) observed IL-4 
mediated inhibitory effect on IL-2 induced secondary influenza virus specific CTL 
induction. Parronchi et al. (1992) reported that early addition of IL-4 to purified 
protein derivative (PPD) specific CD4+ T cells inhibited their differentiation to T hl 
like phenotype and their cytotoxic potential.
IL-5 exhibits no T-cell growth promoting activity on human peripheral blood 
lymphocytes stimulated with antiCD3 or with EBV transformed lymphoblastoid cell 
lines nor does it augment the proliferation induced by IL-2 (Nagasawa et al., 1991). 
Similarly, Ramos, (1989) did not find any proliferation after treatment with IL-5 of 
nylon wool purified murine splenic cells stimulated with G10 purified and gamma 
and U.V. irradiated allogenic PBMCs.
IL-5 has been shown to cause differentiation of specific CTL (Ramos, 1989) as 
well as augmentation of IL-2 mediated LAK activity from murine spleen cells (Aoki 
et al., 1989), IL-5 alone having no LAK inducing activity. In humans, IL-5 
is reported to cause EBV specific CD8+ CTL induction independent of IL-2 
(Nagasawa et al., 1991) with no effect on CD4+ CTL.
IL-6 is reported to directly induce proliferation of highly purified, lectin 
stimulated human T cells (Ceuppens et al., 1988), murine thymocytes and peripheral 
blood T cells (Lotz et al., 1988) independent of IL-2. In contrast, Garman et al. 
(1987) reported that human IL-6 augments proliferation of murine T cells stimulated 
with Con-A or antiTCR antibodies mediated through the production of IL-2. IL-6 
induced human T cells stimulated with PHA to proliferate and this response was 
augmented by IL-1 (Kuhweide et al., 1990). Holsti and Raulet (1989) found that 
highly purified T cells stimulated with antiTCR or antiCD3 did not proliferate to IL- 
6 alone, but required IL-1. This IL-1 and IL-6 induced proliferation is mediated by 
endogenous IL-2, but not IL-4. Similarly, combinations of IL-1 and IL-6 induced IL- 
2 production by alloantigen stimulated murine CD8+ cells (Renauld et al., 1989). IL-
13
6 augments IL-2 mediated (Bertagnolli et al., 1991) and IL-4 mediated (Nagasawa et 
al., 1991; Suda et al., 1990) proliferation of lectia stimulated murine thymocytes. 
AntiIL-6 antibody inhibits a significant component of IL-2 and IL-4 induced 
proliferation, indicating the requirement for endogenous IL-6 (Nagasawa et al. 1991).
Takai et al. (1988) first reported the CTL differentiation activity of IL-6 on 
murine CD8+ thymocytes stimulated with Con-A. Bertagnolli et al. (1991) reported 
the requirement for endogenously produced IL-6 for CTL induction by IL-2 or IL-4 
using Con-A stimulated murine CD8+ thymocytes. Okada et al. (1988) found IL-2 
dependent IL-6 mediated CTL induction in alloantigen stimulated mature human T 
cells, human thymocytes and murine thymocytes. Quentmeier et al. (1992) reported 
the requirement for both IL-2 and IL-4 in IL-6 induced CTL from Con-A stimulated 
murine thymocytes, IL-6 acting as an early factor whereas IL-2 and IL-4 acted as 
late factors in CTL induction. This group further showed the early effect of IL-6 was 
through the induction of IL-2 and IL-4, and that IL-6 did not have any direct CTL 
differentiation activity. Renauld et al. (1989) found that a combination of IL-1 and 
IL-6 induced primary murine allogenic CTL, either cytokine alone having no effect 
with IL-6 acting early making cells responsive to IL-2 and IL-1 acting late inducing 
IL-2 production. Galandrini et al. (1991) found that most of the human CTL clones, 
both CD4+ and CD8+, produced endogenous IL-6 after treatment with IL-2, and that 
this endogenous IL-6 was responsible for CTL activity. IL-6 also augments IL-2 
induced LAK activity from murine thymocytes, and is a late acting factor (Iho et al.,
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1992). Smyth et al. (1990) found that IL-6 and suboptimal IL-2 synergised to induce 
pore-forming protein (PFP) in human T cells, but either one alone did not.
IL-7 is reported to induce proliferation of lectin stimulated murine thymocytes, 
lectin stimulated murine splenic T  cells, lectin stimulated murine peripheral T  cells 
and antigen stimulated human peripheral blood T cells (Morrissey et al., 1989, Welch 
et al., 1989; Grabstein et al., 1990, Londei et al., 1990). Some have reported an IL-2 
requirement for IL-7 mediated proliferation (Morrissey et al., 1989) since antiIL-2 
antibodies inhibited proliferation. IL-7 also induced production of IL-2 and IL-2 
receptor (IL-2R) expression. In contrast, many reports indicated a direct proliferative 
effect of IL-7 on murine thymocytes (Conlon et al., 1989), resting murine T cells 
(Chazen et al., 1989) and mature human peripheral blood T cells (Welch et al., 1989; 
Londei et al., 1990). Still others reported IL-2 dependent and independent 
components for IL-7 mediated proliferation of lectin stimulated, resting murine 
splenic T  cells (Grabstein et al., 1990) and lectin or antiCD3 stimulated human 
peripheral T  cells (Armitage et al., 1990). IL-7 synergised with IL-2 to augment 
proliferation of murine thymocytes (Conlon et al., 1989), human T cells (Welch et 
al., 1989) and with IL-4 or IL-4 and IL-2 to augment murine thymocyte proliferation 
(Conlon et al., 1989). It is proposed that IL-7 may function as a competence factor 
for IL-2 and IL-4 (Chazen et al., 1989). Both CD4+ and CD8+ cells responded 
equally well to IL-7 (Armitage et al., 1990; Welch et al., 1989; Morrissey et al.,
1989), but memory CD45R- cells were better responders than naive CD45+ cells 
(Welch et al., 1989).
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There are many reports that IL-7 augments CTL induction in mixed lymphocyte 
cultures against murine alloantigens (Jicha et al., 1992; Smyth et al., 1991) and 
human alloantigens (Hickman et al., 1990; Alderson et al., 1990). Similarly IL-7 
augments CTL activity of murine mitogen stimulated blasts (Bertagnolli et al., 1990), 
human mitogen blasts (Hickman et al., 1990), human virus stimulated mCTL cultures 
(Hickman et al., 1990) and murine virus stimulated mCTL cultures (Kos et al.,
1993). IL-7 induced cytotoxicity appears to be mediated exclusively by CD8+ cells 
(Hickman et al., 1990; Bertagnolli et al., 1990). Smyth et al. (1991) found PFP 
mRNA was induced in CD8+ cells by IL-7, but not in CD4+ cells or NK cells. Many 
groups have determined that IL-7 mediated CTL induction has both an IL-2 
dependent and independent component (Bertagnolli et al., 1990; Jicha et al., 1992; 
Alderson et al., 1990; Lynch et al., 1991) as demonstrated by partial blockage of 
CTL activity by anti-IL-2 or anti-IL-2R monoclonal antibodies. IL-2 (Bertagnolli et 
al., 1990; Jicha et al., 1992), IL-4 (Bertagnolli et al., 1990) and IL-6 (Bertagnolli et 
al., 1990) were found to augment IL-7 induced CTL activity. Antibodies to IL-2 and 
IL-6 partially blocked IL-7 mediated CTL induction but addition of antiIL-4 did not 
have any effect (Bertagnolli et al., 1990). Other reports indicate that IL-7 directly 
induce at least some subsets of mCTL which are independent of IL-2 (Kos et al.,
1993).
IL-10 was initially described as cytokine synthesis inhibitory factor (CSIF), since 
it was found to suppress the synthesis of HTL derived cytokines (Fiorentino et al., 
1989). After subsequent characterization it was designated IL-10 (Chen et al., 1991).
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IL-10 suppresses accessory cell dependent cytokine production (Fiorentino et al.,
1989; Vieira et al., 1991) and antigen-specific proliferation (Malefyt et al., 1991) of 
clones of T h l cells. IL-10 also inhibits macrophage dependent Con-A induced 
proliferation of CD4+ and CD8+ cells (Ding and Shevach, 1992). Subsequently, it 
has been shown that the inhibition of T hl cell development and function is due to an 
indirect action of IL-10 on macrophage accessory cell function by down regulating 
class II MHC expression (Malefyt et al., 1991; Fiorentino et al., 1991; Ding and 
Shevach, 1992).
IL-10 augments IL-2 and IL-4 dependent proliferation of murine thymocytes and 
T cells (MacNeil et al., 1990), IL-10 alone having no direct proliferative effect. IL- 
10 augments, though to a lesser extent, IL-7 mediated proliferation. Chen et al.
(1991) using Con-A stimulated purified murine splenic CD8+ cell cultures showed 
that IL-10 augmented both the frequency of cells responding to IL-2 as well as the 
rate of proliferation. Further, they showed, using monoclonal antibodies to IL-10, that 
IL-10 has a direct effect on CD8+ cells.
Chen et al. (1991), using limiting dilution cultures, showed that IL-10 augmented 
murine non-specific CTL precursor frequencies and clone size in IL-2 and Con-A 
activated CD8+ splenic T cells. IL-10 caused a 4-8 fold increase in cytotoxicity 
compared to IL-2 alone. IL-10 directly affected CD8+ cells since neutralizing 
antibodies to IL-10 inhibited its effect. They further observed that augmentation of 
cytotoxicity was maximum when IL-10 was added at the onset of culture but was
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also effective when added later, indicating that IL-10 provides signals for both early 
and late stages of differentiation.
London et al., (1986) showed that a combination of IL-2 and a factor produced 
by B lymphoblastoid cells synergised to induce proliferation of purified NK cells, 
and designated it natural killer stimulatory factor (NK.SF). Gately et al. (1986) 
reported a novel factor present in PHA stimulated human PBMC culture supernatant 
distinct from IL-2 which synergise with IL-2 to induce LAK activity and designated 
it cytotoxic lymphocyte maturation factor (CLMF). Isolation and characterization of 
these factors showed NKSF and CLMF to be a identical and the cytokine was 
designated IL-12.
IL-12 augments proliferation of IL-2 activated NK cells (Valiante et al., 1992; 
Gately et al., 1991) and induces a dose dependent proliferation of PHA-stimulated 
(Kobayashi et al., 1989; W olf et al., 1991) and phorbol ester stimulated (W olf et al., 
1991; Kobayashi et al., 1989) peripheral blood lymphocytes, but has only a minimal 
effect on resting lymphocytes. IL-12 induced proliferation appears to be independent 
of IL-2 (Gately et al., 1991), but has an additive effect with suboptimal 
concentrations of IL-2. IL-12 alone caused proliferation of both PHA activated CD4+ 
and CD8+ cells (Wolf et al., 1991). IL-12 alone induced proliferation of CD56+ cells 
and was augmented by suboptimal concentration of IL-2 or IL-7, but not the optimal 
concentration of either cytokine proliferation of IL-2 or IL-7 (Naume et al., 1992). 
IL-12 alone augmented proliferation of T cells recently stimulated with alloantigen or 
solid phase anti-CD3+antibody (Perussia et al., 1992; Bertagnolli et al., 1992). But
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IL-12 alone did not induce proliferation of human T cells stimulated with soluble 
antiCD3+ or PHA or influenza matrix peptide but showed synergistic augmentation 
with IL-2 (Bertagnolli et al., 1992). IL-12 has an inhibitory effect on high dose IL-2 
induced proliferation of fresh (Robertson et al., 1992) or cultured NK or T cells 
(Perussia et al., 1992). The IL-12 inhibitory effect is partially mediated through 
TN Fa (Perussia et al., 1992).
IL-12 induces alloantigen specific human CTL and non specific CTL/LAK 
activity (Valiante et al., 1992). IL-12 mediated nonspecific LAK activity appears to 
be mediated through endogenous T N Fa (Naume et al., 1992; Gately et al., 1992) and 
is independent of IL-2. IL-12 induced antigen specific CTL activity requires IL-2 
(Gately et al., 1986; Wong et al., 1988; Kobayashi et al., 1989; Stern et al., 1990; 
Gately et al., 1992) and IL-12 appears to act as a late factor in this response (Wong 
et al., 1988).
Summary
In addition to the antigen specific signal, nonspecific signals in the form of 
cytokines are required for CTL induction. Multiple cytokines have been shown to 
provide the secondary signals required for CTL induction. While most studies have 
focussed on the role of different cytokines in the generation of a primary CTL 
response, less is known regarding the role of cytokines and other signals in the 
generation of a mCTL response. Since mCTL play a critical role in protection against 
influenzal disease, the identification of those cytokine necessary for influenza virus
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specific mCTL induction could lead to the development of better therapies. The 
present study attempts to determine the minimal signals required for influenza virus 
specific mCTL induction, and the role of known cytokines in the regulation of this 
response.
The specific aims of this study were:
1. To analyse the minimal signal requirement for mCTL induction.
2. To check the ability of other known cytokines in CTL induction.
3. To verify the regulatory role of IL-2 and IL-4 in mCTL induction.
Chapter 2 
MATERIALS AND METHODS
Culture Media
RPMI-1640 (Gibco BRL, Gaithersburg, MD) containing 10% fetal calf serum 
(FCS, Hyclone Laboratories Inc., Logan, UT) penicillin (lOOu/ml), streptomycin 
(100fjgm/ml)(Pfizer, New York, NY) and 2mM glutamine (Sigma Chemical 
Company, St. Louis, MO) was used in all experiments.
Preparation of Cells
Ficoll-Paque. Blood was collected from random healthy donors and processed to 
obtain buffy coats by the Earl K. Long Memorial Hospital blood bank staff, Baton 
Rouge, LA. Buffy coats were further enriched for mononuclear cells by 
centrifugation at 750 x g for 15 minutes. Peripheral blood mononuclear cells (PBMC) 
were subsequently isolated by differential sedimentation through a Ficoll-Paque 
(Pharmacia LKB Biotechnology Inc., Piscataway, NJ) gradient (400 x g, 25 minutes). 
The interface containing PBMCs was collected and washed (200 x g, 7 minutes) 
thrice in excess Ca2+, Mg2+ free phosphate buffered saline (CMF-PBS) and finally 
resuspended in media. Cells were prepared fresh for each experiment and viability 
determined using the trypan blue exclusion method.
Nylon wool column. T lymphocytes were enriched from PBMCs by incubating 
the cells in a nylon wool (Poly Sciences, Warrington, PA) column for 60 minutes at
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37°C, and eluting out the non-adherent T  cells using pre-warmed media. Usually a 
single column containing 2.4 grams of pre-treated nylon wool was used for each 
buffy coat containing 6 x 108 PBMCs.
Percoll gradient. The small, resting, high density T lymphocytes (SmT) were 
separated from large granular lymphocytes (LGL) using a continuous percoll 
(Pharmacia Fine Chemicals, Uppsala, Sweden) gradient (Ravnik et al., 1988). Briefly, 
the nylon wool purified T cells were resuspended in 10 mis of 58% isotonic percoll 
and centrifuged at 30,000 x g (17,500 RPM in Sorvall RC-5B centrifuge) for 10 
minutes at 4°C. The lower band containing the SmT was collected and washed once 
in an excess of CMF-PBS and resuspended in media.
Cell sorting and analysis. Percoll purified SmT cells were found to be >90% T 
cells as shown by fluorescent activated cell sorter (FACS) (Becton-Dickinson, 
Mountain View, CA). They were further enriched for CD4+ and CD8+ subsets using 
FACS after labelling the SmT cells with specific fluorochrome-labelled monoclonal 
antibodies (DAKO Corporation, Carpinteria, CA), sorter purified cells were >99.99% 
pure.
Stimulators. Stimulators were prepared by infecting PBMCs with influenza 
A/Mississippi virus for four hours and either fixing the cells with 0.5% formaldehyde 
for 10 minutes or irradiating the cells with 2000 rads of gamma rays from a 60Co 
source. The treated cells were washed thrice with CMF-PBS and resuspended in 
fresh media before use. Uninfected PBMCs, treated identically, were used as 
controls.
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Targets. Targets were prepared as follows: 107 PBMCs were cultured in 25 cm2 
flasks (Coming, New York, NY) in lOmls of media in the presence of 2pgm/ml of 
pokeweed mitogen (PWM) (Sigma Chemical Company) for 5 days. On the fifth day, 
the cultures were split 1:1 with fresh media so that the cells remained in the log 
phase of the cell cycle. On the sixth day, the cells were washed and viability was 
determined. The cells were infected with influenza virus, 0.1 ml of virus stock for 
every 107 cells, overnight at 37°C. Uninfected controls were incubated in medium. 
The cells were then labelled with N a /’CrQ, (NEN Research Products, Boston, MA), 
lOOpCi in 0.1ml of PBS for every 106 cells. The targets were then washed twice with 
fresh media with 30 minutes incubation at 37°C between the washes and resuspended 
at 4 x 104cells/ml in media.
Conditioned Media
Cytokine containing conditioned medium (CM) was prepared by culturing 107 
PBMCs with 2pgm/ml of PWM in lOmls of medium for two days. The supernatant was 
collected, aliquoted at 2mls and stored at -20°C until used.
Cytokines
Recombinant human cytokines were used in all experiments and were obtained 
from the following sources; IL-2 (Cellular Products, Buffalo,NY), IL-5 (R&D 
Systems, Minneapolis,MN), IL-6 (Boehringer Mannheim, Gmbh, Germany), IL-1, IL-
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4, IL-7 and IL-10 (Biosource Intl., Camarillo, CA). Human recombinant IL-12 was 
kindly provided by Dr. Maurice Gately (Hoffmann-La Roche, Nutley, NJ).
Antibodies
All fluorochrome labelled monoclonal antibodies used in cell sorting were 
purchased from Becton-Dickinson. Polyclonal neutralizing antibodies to IL-2, IL-4 
and IL-7 were purchased from R & D System.
Virus Stocks
Influenza virus A/Mississippi (H3N2), obtained from Dr. Roland Levandowski 
(FDA, Bethesda), was propagated in embryonated hen’s eggs. Allantoic fluid 
containing the virus was aliquoted in 1.0 ml volumes and frozen at -70°C until used. 
The titre was 80 hemagglutination units per ml (80 HAU/ml).
Bulk Cultures
300,000 stimulators and an equal number of responders were placed in 96 well 
round bottomed plates (Coming) in quadruplicates. Cytokines and/or antibodies were 
added at the time and dose indicated for each experiment. On the last day of the 
experiment, three fold dilutions of the cultures were made and 2000 labelled target 
cells were added to each well. Given that the viable cell count after seven days of 
culture is typically 30%, the effective E/T ratios were 30 and 10:1. Each experiment 
was repeated with blood from at least four different donors.
24
Microcultures
Microcultures were established using a modification of a previously described 
protocol (Kaminski et al., 1991). Each cytokine was tested in 32 replicates in 96 well 
round-bottomed plates. Each replicate culture contained 20,000 stimulators and
50,000 responders, prepared as previously described. Cytokine(s) and/or anticytokine 
antibodies were added at the time and dose indicated for each experiment. Each 
experiment was repeated with blood from at least four different donors.
Cytotoxicity Assay
Cytotoxicity was assessed by the method described by Erard and coworkers 
(1985). On the seventh day of culture, 50pl of labelled target cell (see above) 
suspension containing 2000 cells was added to each well. The plates were 
centrifuged at 50 x g for 5 minutes and incubated for 4 hours at 37°c in a C 0 2 
incubator (Forma Scientific, Marietta, OH). Supernatant fluids from each well were 
collected using the supernatant collection system (Skatron, Sterling, VA) and then 
counted in a gamma counter (Pharmacia LKB Biotechnology Inc.). Percent specific 
cytotoxic activity was determined as (Experimental - Spontaneous)/(Total - 
Spontaneous) x 100%. For microcultures, positive wells were identified as those 
wells with percent specific lysis greater than 2 standard deviation of the mean counts 
for wells containing targets only. For bulk cultures, the cytotoxicity is expressed 
either as the percent specific lysis for two different E/T ratios or as lytic units. Lytic
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unit is defined as the amount of lysis per 107 effectors at 20% lysis of the targets, 
and is calculated using the computer program BRMBASIC.
Proliferation Assay
Lymphocyte proliferation was measured by 3H-thymidine (New England Nuclear) 
incorporation into DNA during the last 20 hours of culture. The DNA was harvested 
onto glass fiber filter paper (Tomtech-Wallac, Finland) using a 96 well harvester 
(Tomcom-Wallac) and each filter was sealed in a polyethylene bag to which was added 
lOmls of liquid scintillation cocktail (ICN Biomed. Irvine, CA). Beta counts were 
measured using a liquid scintillation spectrophotometer (LKB-Wallac, Finland). Mean 
proliferative response is expressed as counts per minute (CPM) and stimulation indices 
(SI) was calculated as a ratio of mean CPM for experimental wells and the mean CPM 
for control wells containing cells incubated with medium alone.
Chapter 3
INFLUENZA VIRUS SPECIFIC MEMORY CTL INDUCTION 
MINIMAL SIGNAL REQUIREMENT
Introduction
Though mCTLs are present in the peripheral blood shortly after the initial 
exposure to antigen, their derivation is still unclear (McFarland et al., 1992). Whether 
these cells are quiescent primary CTLs or a separate lineage of cells derived from 
naive CTL precursor cells is not clear. Distinct functional differences exist in terms 
of cytokine production and responsiveness, but little is known about the differences 
in signal requirements for the activation of memory and naive cells.
The two signal model of lymphocyte activation postulates that two signals are 
required, one provided through the interaction of the T-cell receptor with antigen- 
MHC complex on the antigen presenting cells (APC) which is highly specific, and a 
second signal, which is non-specific and is provided through the interaction of 
cytokines with their receptors on lymphocytes. Many reports suggest the requirement 
for a third signal for CTL differentiation (Hardt et al., 1985; Gromo et al., 1987; 
Horohov et al., 1988a).
It is postulated that mCTL induction does not require antigenic restimulation, 
only a soluble signal provided by IL-2 (Erard et al., 1985; Yoshimoto et al., 1985). 
This model is consistent with the assumption that some of the primary effector CTLs 
become quiescent mCTLp in the absence of antigen. The alternative postulate is that 
mCTLp are derived separately from primary CTL, though generated from the same
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precursor T cell after the initial antigen encounter. These mCTLp, like primary CTL, 
may require multiple signals including differentiation factors in order to become 
cytotoxic (Owen et al., 1982). No clear cut demonstration of the existence of any one 
mechanism has yet been reported.
In this chapter I have attempted to identify the minimal signal requirements for 
memory CTL induction using influenza virus as the specific antigen. Since >90% of 
the adult human population has been exposed to influenza and has mCTLp in their 
peripheral blood, in vitro assays can be used in ’add back’ experiments to determine 
the minimal signal requirement for virus specific CTL induction.
Results
Antigen restimulation is required fo r  antigen specific memory CTL induction. 
Limiting-dilution micro-cultures were used to test the requirement for antigenic 
restimulation in mCTL induction. FACS sorted CD8+ cells were used as the 
responders and y-irradiated, influenza virus infected or uninfected PBMCs were used 
as stimulators. IL-2 (25u/ml) and CM (see materials and methods) (20% v/v) were 
used in all cultures so that necessary soluble factors were provided. While a small 
subset of T cells became cytotoxic without antigenic restimulation, the majority of 
the influenza virus specific mCTLp appear to require antigenic reencounter for 
mCTL induction (Figure 3.1).
IL-2 enhances mCTL induction from  antigen stimulated CD8+ cells. The 
previous experiment showed that cultures containing CD8+ cells, antigen specific
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Figure 3.1 Antigenic restimulation is required for mCTL induction. Limiting dilution 
microcultures consisting of uninfected (uninfect.) influenza virus infected (Infect.), 
irradiated stimulators, CD8+ responder cells and cytokines (IL-2, CM) were 
incubated for 7 days and assayed for cytotoxicity against influenza virus infected 
autologous PBMCs. Results are expressed as the percentage of positive wells out of 
32 replicate cultures.
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stimulators, IL-2 and CM generated cytotoxicity. Since others had reported that IL-2 
alone could support mCTL induction, the experiment was repeated, this time without 
adding CM to the cultures. As shown in Figure 3.2, IL-2 significantly augmented 
mCTL induction in influenza virus stimulated cultures in the absence of CM.
Cultures containing only irradiated stimulators and responders also showed a 
significantly higher cytotoxicity than the stimulators only control, indicating a role 
for endogenously produced IL-2 or other cytokines.
IL-2 has an indirect effect on mCTL induction. Since some of the cultures 
containing only CD8+ cells and irradiated stimulators generated cytotoxicity (Figure- 
3.2), cytokine production by the irradiated accessory cells appeared likely. To 
completely eliminate endogenous cytokine production by the stimulators cells, 
formaldehyde fixed stimulators were used and compared to irradiated stimulators in 
the limiting dilution cultures. The results shown in Figure 3.3 demonstrate that IL-2 
induced cytotoxicity only when irradiated stimulators were used indicating an indirect 
effect of IL-2 on mCTL induction.
Soluble factor(s) present in the conditioned media are required fo r  maximal 
mCTL induction. Since IL-2 failed to provide the necessary signal for CTL induction 
in microcultures using fixed stimulators, I tested the ability of a cytokine cytokine 
containing CM to restore CTL generation in these cultures. Our results (Figure 3.4) 
show that some soluble factors present in the CM is required for mCTL induction, 
and corroborate the previous observation that IL-2 alone is not a sufficient. This also 
indicates that under optimal conditions fixed cells can function as APCs.
30
100
v^ ,
m m grnm ^  ,<5.: ■
M M***<'*' /< h I
Stim s-rad Stim s-rad Stims-rad
CD-8+ CD-8+
IL-2
Figure 3.2 IL-2 augmented cytotoxicity induction when CD8+ cells and irradiated 
stimulators are used. Limiting dilution microcultures consisting of virus infected, 
irradiated stimulators (Stims-rad), CD8+ responder cells, and IL-2 were incubated for 
7 days and assayed for cytotoxicity against influenza virus infected autologous 
PBMCs. Results are expressed as the percentage of positive wells out of 32 replicate 
cultures.
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Figure 3.3 IL-2 has an indirect effect on mCTL induction. Limiting dilution 
microcultures consisting of influenza virus infected, formaldehyde fixed (Stims-fix) 
or irradiated (Stims-rad) stimulators, CD8+ responders and IL-2 were incubated for 7 
days and assayed for cytotoxicity against influenza virus infected autologous PBMCs. 
Results expressed as percentage of positive wells out of 32 replicate cultures.
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Figure 3.4 The induction of mCTL requires additional cytokines. Limiting dilution 
microcultures consisting of influenza virus infected, fixed stimulators (Stims-fix), 
CD8+ responders, and cytokines (IL-2, CM) were incubated for 7 days and assayed 
for cytotoxicity against influenza virus infected autologous PBMCs. Results 
expressed as the percentage of positive wells out of 32 replicate cultures.
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Discussion
The minimal signal requirement for mCTL induction remains controversial. 
Conflicting reports exist regarding the requirement for antigen (Gray et al., 1991; 
Yoshimoto et al., 1985). This discrepancy could be due to variations in the assay 
systems used. While T cells from mice primed two months earlier contain memory 
cells (Yoshimot et al., 1985), they may also contain primary CTL whose cytotoxicity 
is augmented with IL-2. This effect may also be seen with healthy human donors 
some of whom may have been recently exposed to influenza virus. To minimize this 
effect, I used percoll gradient purified small T lymphocytes. This denser, resting 
population would contain quiescent cells and few activated cells. Using this 
population I found an essential requirement for antigenic restimulation for the 
majority of mCTLp, although a small subset could become cytotoxic in the presence 
of IL-2 without antigenic stimulation (Figure-3.1).
In most studies, irradiated cells have been used as stimulators. While irradiation 
inhibits cell division, it does not prevent the cells from secreting soluble factors.
Thus the reported effects of exogenously added cytokines may actually be indirect 
when irradiated cells were used. I used two different approaches to reduce 
endogenous cytokine production. By using microcultures the amount of endogenous 
cytokine produced was reduced by limiting the number of antigen-reactive cells in 
each well. By fixing the stimulator cells with formaldehyde, cytokine production by 
these cells was eliminated. Although it is possible that formaldehyde fixation might 
destroy surface antigenic structures, it has been previously demonstrated that
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formaldehyde fixed PBMCs can function as APCs to mCTL precursors (mCTLp) 
(Kozinowski and Simon, 1979; Jennings et al., 1988). I show here that virus infected, 
formaldehyde fixed cells could function as APC in our assay system when 
conditioned medium was added as a source of cytokines (Figure 3.4).
The role of cytokines in mCTL generation is controversial. While some have 
reported that IL-2 is sufficient for mCTL induction (Yoshimoto et al., 1985; Owen et 
al., 1982), others report the requirement for additional factors (Takai et al., 1986; 
Bertagnolli et al., 1991). I have shown that IL-2 could provide the necessary signal 
for maximal mCTL induction when irradiated stimulators were used, but not if fixed 
cells were employed. The conclusion from these results is obvious, IL-2 appears to 
induce the production of other cytokines by the irradiated stimulators and was thus 
acting indirectly to induce mCTL generation. In the presence of fixed stimulators, 
other cytokines had to be exogenously provided (in the CM) to induce mCTL 
generation. In subsequent chapters I have examined the possible role of other 
cytokines in providing this additional signal.
Chapter 4
REGULATION OF HUMAN MEMORY CTL RESPONSES BY CYTOKINES
Introduction
Humoral antibodies may be ineffective in providing protection against some viral 
infections (Clerici et al., 1991). Since cytotoxic T lymphocytes (CTL) appears to play 
a central role in the recovery from some infections (Klavinskis et al., 1989; 
McMichael et al., 1983), the induction of a memory CTL (mCTL) response may be 
necessary for long term protection.
The induction of a mCTL response is a multistep process. The recognition of 
specific antigen complexed with MHC on stimulator cells induces responsiveness to 
subsequent non-specific signals mediated by cytokines. CD4+ T cell derived soluble 
factors (Biddison et al., 1981; Braakman et al., 1986; Mizuochi et al., 1989; Renauld, 
et al., 1989), and in some cases CD8 helper cell derived factors (Fishwild et al.,
1988; Jennings et al., 1991) are involved in mCTL induction. Detailed analysis of 
these T cell derived factors is not yet complete.
Previous reports indicated a direct role for IL-2 (Kos et al., 1993), IL-4 (Horohov 
et al., 1988b), IL-5 (Nagasawa et al., 1991) and IL-7 (Hickman et al., 1990) in 
mCTL induction and an indirect role for IL-1 (Renauld et al., 1989) and IL-6 
(Quentmeier et al., 1992). IL-10 (Chen et al., 1991) and IL-12 (Gately et al., 1992) 
are two recently described cytokines with various effects on T cells, but their role in 
antigen specific mCTL induction has not been determined. Multiple cytokines have
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been reported to induce influenza virus specific mCTL in vitro (Horohov et al.,
1988a; Hickman et al., 1989; Kos et al 1993). The ability of a cytokine to modulate 
the induction of cytotoxicity was shown to be dependent on the time and dose of the 
cytokine used (Horohov et al., 1988b).
In this report, eight different recombinant cytokines (IL-1, IL-2, IL-4, IL-5, IL-6, 
IL-7, IL-10 & IL-12) were tested for their ability to induce Influenza A virus specific 
mCTL in vitro. These cytokines were selected because of their ready availability as 
recombinant products and their reported role in CTL induction. I show here that 
cytokines IL-4, IL-7, IL-10 and IL-12 can cause mCTL induction from antigen 
stimulated small T lymphocytes.
Results
IL-4, IL-7, IL-10 and IL-12 augment influenza virus specific memory CTL 
induction. I tested eight different cytokines (Figure 4.1) for their ability to induce 
antigen specific mCTL in bulk cultures. IL-4, IL-7, IL-10, and IL-12 augmented 
cytotoxicity. The effect of these cytokines on CTL generation varied with the time of 
addition to the culture. Thus IL-4 and IL-12 induced a maximum response when 
added three days after the initiation of the culture. IL-7 induced maximum response 
on day-1 and its effect decreased with time. IL-10 appears to have comparable effect 
both early as well as late.
Dose response o f  IL-7, IL-10 and IL-12. In the previous experiments the 
concentration of the cytokines used was based on earlier reports of optimal
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Figure 4.1 IL-4, IL-7, IL-10 and IL-12 enhance influenza virus-specific mCTL 
induction. Cultures containing small T lymphocytes (3 x 105/well/0.2ml) and an equal 
number of influenza virus infected and fixed autologous PBMCs were supplemented 
with various cytokines on day 1, day 3 or day 5 and incubated for 7 days. Cultures 
were assayed for cytotoxic activity against influenza virus infected autologous 
PBMCs and results are expressed as lytic units (see materials and methods). Results 
are from at least 6 donors.
38
concentration in other biological assays. To determine the optimal dose for each of 
these cytokines in mCTL induction, I tested IL-7, IL-10 and IL-12 at concentrations 
ranging from 1 to 100 u/ml. All three cytokines showed a concentration dependent 
augmentation of cytotoxicity (Figure-4.2) with the highest concentration of cytokine 
being less effective than the optimal dose.
IL-7, IL-10 & IL-12 induce Influenza virus specific cytotoxicity. I tested our 
assay system for non-specific killer activity using uninfected autologous cells as 
targets. Addition of IL-7, IL-10 or IL-12 to influenza virus stimulated bulk cultures 
of small T lymphocytes induced minimal nonspecific killing (Figure-4.3) as 
compared to the lysis of virus infected targets. These results indicate that the 
majority of killer cells were influenza virus specific. I also tested the specificity of 
killing using a cold target inhibition assay. Addition of Daudii cells, a LAK sensitive 
human B-lymphoblastoid cell line, failed to block killing of virus infected targets 
(data not shown). Addition of cytokines to unstimulated T cell cultures also failed to 
induce virus specific cytotoxicity (data not shown). Together these results indicate 
that the cytokines specifically augmented influenza virus specific mCTL induction.
IL-10 and IL-12 augment CTL induction without inducing proliferation.Since 
mCTLp have already proliferated during the initial antigen encounter they can 
become effector cytotoxic cells without additional proliferation (Owen et al., 1983). 
Alternatively proliferation of the precursors may be required in order to increase the 
number of effector cells and enhance the anamnestic response. The third possibility is 
that multiple subsets of memory cells exists, some requiring proliferation while
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Figure 4.2 IL-7, IL-10 and IL-12 induce dose dependent cytotoxicity. Cultures 
containing small T  lymphocytes (300,000/well/0.2ml) and equal numbers of influenza 
virus infected and fixed autologous PBMCs were supplemented with IL-7, IL-10 or 
IL-12 on the day they showed maximum response (Figure 4.1), at doses of no 
cytokine (o-o), lu  (□-□), lOu (■-■), and lOOu ( ♦ - ♦ )  per ml. Cytotoxicity was 
assayed on day 7 in an 4 h 51Cr release assay against autologous influenza virus 
infected PBMCs. Lytic activity expressed as percent specific lysis at two different 
E/T ratios.
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Figure 4.3 IL-7, IL-10 and IL-12 induced cytotoxicity is influenza virus specific. 
Cultures containing small T  lymphocytes (300,000/well/0.2ml) and equal numbers of 
influenza virus infectded, fixed autologous PBMCs were supplemented with IL-7, IL- 
10 and IL-12 at the optimal time (Figure 4.1), and dose (Figure 4.2). On day 7, 
cytotoxic activity of the culture was determined against influenza virus infected 
(■-■) or uninfected ( ♦ - ♦ )  autologous PBMCs. Lytic activity is expressed as the 
percent specific lysis at two different E/T ratios.
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others do not. I tested IL-7, IL-10 and IL-12 for their ability to induce T  cell 
proliferation in our assay system. As shown in Table 4.1, only IL-7 induced any 
significant proliferation in the influenza virus stimulated cultures.
IL-7 induced proliferation has both specific and non specific components. Since 
IL-7 induced significant proliferation of antigen stimulated cultures, I tested the 
characteristics of IL-7 induced proliferation. As shown in Figure-4.4, IL-7 alone 
induces a dose dependent proliferation of T  cells in the absence of antigen 
stimulation and enhanced proliferation when antigen was present.
IL-4, IL-7 IL-10 and IL-12 augment mCTL generation in micro-cultures. Our use 
of fixed stimulators minimized endogenous cytokine production, but it is arguable 
that in bulk cultures large numbers of responder T-cells may themselves produce 
enough cytokines to affect mCTL induction. Therefore I tested IL-4, IL-7, IL-10 and 
IL-12 in microcultures containing 20,000 small T cells per well as responders and 
50,000 fixed stimulators. These results (Figure 4.5) corroborate our earlier findings 
from bulk cultures. To reaffirm that the observed effects of exogenously added 
cytokines are indeed mediated by cytotoxic cells, I tested them again with highly 
purified CD8+ cells and added cytokines in microcultures, these results also 
corroborate our earlier findings (data not shown).
Discussion
I have examined the ability of eight different recombinant cytokines to augment 
influenza virus specific mCTL induction. Recombinant IL-4, IL-7, IL-10 and IL-12
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Table 4.1
IL-7 augments T cell proliferation
Cytokines
Added
Proliferation, CPM
Expt.l, Donor #139 Expt.2, Donor #141
Day-4 Day-7 Day-4 Day-7
None 278 ± 88.6 550 ± 150.6 722 ± 108.3 383 ± 70.8
IL-7 680 ± 192.1 3362 ± 262.8 2555 ± 351.7 7424 ± 1603.1
IL-10 161 ± 18.7 124 ± 53.6 1087 ± 231.2 341 ± 133.7
IL-12 215 ± 60.7 509 ± 108.7 1096 ± 138.9 681 ± 85.4
Cultures consisting of small T lymphocytes, influenza virus infected and fixed 
autologous PBMCs and cytokines were incubated for 7 days. Proliferation assayed on 
day 4 or day 7 as 3H-TdR incorporation during the last 20 hours of culture and 
results expressed as mean ± standard deviation CPM (n=4).
43
X
5a,
U
co
• »H
C3
i - .O
6  o o c
<uc
'• $
s
£
10
8
6
4
2
0
0 1.0 10 100
IL-7 Concentration, ng/ml.
F igure 4.4 IL-7 induced proliferation has both antigen dependent and independent 
components. Cultures containing purified small T  lymphocytes (100,00/well/0.2ml) 
alone or with equal number of influenza virus infected, fixed autologous
PBMCs (P-B) were supplemented with IL-7 (lu/m l) on day 1. Proliferation assayed 
on day 4 as 3H-TdR incorporation during the last 20 hours of culture.
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Figure 4.5 IL-7, IL-10 and IL-12 induce influenza virus specific cytotoxicity in 
microcultures. Limiting dilution microcultures consisting of small T lymphocytes, 
influenza virus infected, fixed stimulators and cytokines (added on day 1, day 3 or 
day 5) were incubated for 7 days and assayed for cytotoxicity against influenza virus 
infected autologous PBMCs. Results are expressed as percentage of positive wells 
out of 32 replicate cultures and are the average of 8 separate donors.
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all induced influenza virus specific cytotoxic T cells in a time and dose dependent 
manner. Our results here also demonstrate that cytokine induced mCTL induction 
could occur in the absence of proliferation, possibly by providing a differentiation 
signal.
The role of cytokines in mCTL induction remains controversial. There have been 
several reports indict-mg that IL-2 alone is sufficient to induce mCTL (Erard et al., 
1985, Yoshimoto et al., 1985) whereas other reports indicate a requirement for 
additional factor(s) distinct from IL-2 for mCTL induction (Horohov et al., 1988, 
Kaminski et al., 1991). These differences are probably due to the variations in the 
assay systems used. In our system I could not find any significant mCTL induction 
by IL-2 in antigen stimulated cultures (Figure-4.1), indicating that other cytokines 
may be playing a role in mCTL induction (Horohov et al., 1988a, 1988b; Chapter 3).
I tested eight cytokines for their ability to induce secondary CTL after antigenic 
stimulation in the absence of IL-2. I provide evidence here that IL-4, IL-7, IL-10 and 
IL-12 can induce secondary CTL from antigen stimulated cultures. IL-2 is neither 
required nor is sufficient for secondary CTL induction.
Since the addition of cytokines to lymphocyte cultures can result in the 
production of other cytokines, it is not always possible to distinguish between direct 
and indirect effects of a given cytokine. Previous reports indicating a direct role for 
IL-2 (Erard et al., 1985, Yoshimoto et al., 1985) and IL-5 (Nagasawa et al., 1990) 
were reported may in fact represent a requirement for additional endogenously 
produced factors. I have hoped to minimize this problem by using highly purified
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(>90% CD3+) T-cells as responders, influenza virus infected fixed PBMCs as 
stimulators, and microcultures.
It is known that different cytokines may each affect a different stage of CTL 
generation and a single cytokine may affect multiple stages. In this study, I have 
looked at those cytokines which can induce secondary cytotoxicity after antigenic 
stimulation. IL-4 was reported to affect CTL differentiation (Horohov et al., 1988b).
I found that in a seven day culture period, addition of IL-4 on day-3 gave maximum 
cytotoxicity compared to earlier addition (Figure-4.1). This augmentation was not due 
to proliferation of the antigen stimulated T cells, as previously reported, and 
probably reflected a differentiation signal. Hickman et al (1990) have previously 
shown that IL-7 augments influenza virus specific mCTL generation and induced 
proliferation of T  cells. I observed a similar effect of IL-7 in our system and I 
conclude that IL-7 has both proliferation and differentiation activity on mCTL 
induction.
IL-10 has been reported to have, among its many other effects, proliferation and 
differentiation activity on murine T cell (Chen et al., 1991; MacNeil et al., 1990). 
Chen et al (1991) first reported this CTL differentiation activity for murine splenic 
CD8+ cells stimulated with Con-A and IL-2, IL-10 alone having no effect on Con-A 
activated cells. I observed that human IL-10 could augment human influenza virus 
specific mCTL induction (Figure-4.1), though no significant effect on proliferation 
was observed. Kinetic studies reported by Chen et al., (1991) indicated that IL-10
47
may be effective at both early and late stages of CTL differentiation. Our result 
demonstrate a similar pattern of activity in the mCTL cultures.
IL-12 is reported to have proliferative effects on activated T and NK cells 
(Gately et al., 1991) and enhances NK and LAK activity (Gately et al., 1986; Gately 
et al., 1992). In addition, IL-12 augments the generation of human allogeneic CTL 
(Gately et al., 1992) in the presence of IL-2, thus DL-12 appears to be a late acting 
factor (Gately et al., 1992). Here I report that IL-12 could induce Influenza virus 
specific mCTL (figure-4.1), but it did not augment the proliferation of the antigen 
stimulated T-cells. Like IL-4, IL-12s maximal effect occurred when added late to the 
cultures and thus appears to behave as a differentiation factor for memory CTL.
Our results demonstrate that multiple cytokines can induce the differentiation of 
mCTLp into effector mCTL. Others have reported similar activities in other system 
(Hickman et al., 1989; Chen et al., 1991). These results then indicate that the 
intracellular signals necessary for mCTLp differentiation can be provided either by 
multiple mechanisms or that the binding of each cytokine to its receptor results in the 
generation of a common signalling pathway (Miyajima et al., 1992). Which cytokines 
provide the necessary signals in vivo may be determined by the local environment. 
Indeed, specific cytokines may only be elicited under certain conditions. The 
commonality of their effects on mCTL differentiation thus allows for mCTL 
generation under a variety of conditions.
Chapter 5
IL-2 AND IL-4 DIFFERENTIALLY REGULATE 
INFLUENZA VIRUS SPECIFIC MEMORY CTL
Introduction
The generation of CTL from their precursor is a multi-step process involving 
accessory cells and cytokines (O’Rouke et al., 1992; Takai et al., 1986). Multiple 
cytokines may be required at individual steps, or individual cytokines may act at 
multiple steps depending on the stage of maturation or differentiation (Horohov et 
al., 1988a, 1988b; Chapter 4). It is arguable that mCTLp with different signal 
requirements exist, and that maximal cytotoxicity induction may require more than 
one cytokine.
Various reports indicate that IL-2 has T cell proliferation as well as 
differentiation activity (Cantrell and Smith, 1983; Yoshimoto et al., 1985; Palladino 
et al., 1991; Fishwild et al., 1988). I did not find any mCTL inducing activity by IL- 
2 when formaldehyde fixed antigen presenting cells were used (Chapter 3), indicating 
an indirect effect of IL-2 on mCTL induction. IL-2 was also reported to have 
augmenting effects on nonspecific cytotoxicity induction by IL-7 (Bertagnolli et al.,
1990), IL-10 (Chen et al., 1991) and IL-12 (Gately et al., 1986), but a modulatory 
role for IL-2 in their activity in antigen specific mCTL induction has not yet been 
determined.
IL-4 have been reported to be involved at various stages of CTL differentiation 
and maturation (Quentmeier et al., 1992; Bertagnolli et al., 1991; Horohov et al.,
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1988b; Widmer et al., 1987). IL-4 has both a CTL enhancing (Horohov et al., 1988) 
as well as inhibitory activity (Widmer et al., 1987; Horohov et al., 1988b; Palladino 
et al., 1992; Parronchi et al., 1992; Abehsira-Amar et al., 1992) on mCTL induction 
depending upon the time of addition. Further, it is not yet clear whether the effect of 
IL-4 is mediated directly on the T  cells or indirectly through accessory cells. Hsieh et 
al., (1993) have recently reported that the effect of IL-4 is much stronger than that of 
IL-12 for T cell differentiation when both cytokines are present together. So, it was 
of interest to determine the effect of IL-4 in combination with other mCTL inducing 
cytokines, IL-7, IL-10 and IL-12.
In this chapter I report the results from experiments using combinations of 
cytokines, IL-2 or IL-4, with IL-7, IL-10 and IL-12 on mCTL induction. AntiIL-2 or 
IL-4 antibodies were also used in some experiments to block any endogenously 
produced cytokines. Thus addition of IL-2 had little effect on cytotoxicity induction 
by IL-7, IL-10 and IL-12, likewise antiIL-2 did not completely block their mCTL 
induction indicating an IL-2 independent mechanism. IL-4 on the other hand, had 
both inhibitory as well as augmenting effect on CTL induction by IL-7, IL-10 and 
IL-12 depending on the time of addition of IL-4.
Results
IL-7, IL-10 and IL-12 induced cytotoxicity is independent o f  IL-2. IL-2 was 
added in combination with the various cytokines to bulk cultures to determine its 
effect on influenza virus specific mCTL induction (Table 5.1). While some minimal
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increase in cytotoxicity was occasionally observed (eg. Donor 108), there was no 
consistent effect of IL-2 addition on mCTL induction. Likewise, addition of a 
neutralizing antiIL-2 antisera to the cultures also failed to consistently reduce the 
level of cytotoxicity. These results indicates that mCTL induction by IL-7, IL-10, and 
IL-12 is independent of IL-2.
Early addition o f  IL-4 is inhibitory to mCTL induction. When IL-4 was added 
early to cultures containing either IL-7, IL-10 or IL-12 there was a significant 
inhibition of the cytotoxic response induced by these cytokines (Table 5.2). Likewise 
antiIL-4 added at the onset of the cultures resulted in an increased cytotoxic 
response. This observation corroborates earlier reports of an early inhibitory effect of 
IL-4.
IL-2 is augmentory whereas IL-4 is inhibitory to IL-7 m ediated proliferation. IL- 
2 augmented IL-7 mediated proliferation, but antiIL-2 blocked only a minor 
component of IL-7 proliferation indicating an IL-2 independent pathway for IL-7 
induced proliferation (Table 5.3). In contrast, IL-4 decreased IL-7 mediated 
proliferation, and antiIL-4 augmented proliferation (Table 5.4).
IL-10 and IL-12 augment IL-2 and IL-4 induced proliferation o f  T cells. While 
IL-10 and IL-12 failed to augment proliferation in the virus stimulated cultures 
(Table 5.5), the addition of either cytokine to cultures containing either IL-2 or IL-4 
resulted in an increase in proliferation. This increase was above that observed when 
any of the cytokines were added alone. These results indicates that while neither IL-
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Table 5.1
IL-2 has a minimal effect on mCTL induction.
Cytokines/
Antibodies
Cytotoxic Activity, Lytic Units
Donor Number
108 122 129
None 0 18 14
IL-2(1) 36 92 33
IL-7(1) 157 149 94
IL-10(5) 209 118 54
EL-12(5) 11 87 38
IL-2, IL-7 181 143 126
IL-2, IL-10 247 ND 52
IL-2, IL-12 14 ND 46
antiIL-2, IL-7 ND 167 90
antiIL-2, IL-10 ND 39 56
antiIL-2, IL-12 ND 89 46
Cultures containing small T lymphocytes (300,000 cells/well/0.2ml) and equal 
number of influenza virus infected, fixed autologous PBMCs were supplemented with 
cytokines (on day mentioned in parenthesis) or antibodies (at the onset of culture).
On day 7, cytotoxic activity of the cultures was determined against influenza virus 
infected autologous PBMCs and results are expressed as lytic units at 20% lysis for 
107 cells. ND - Not done.
52
Table 5.2
IL-4 has both positive and negative regulatory effects on mCTL induction.
Cytokines/
Antibodies
Cytotoxic Activity, Lytic Units
Donor Number
108 122 129
None 0 18 14
IL-4(1) 0 ND 19
IL-7(1) 157 149 94
IL-10(5) 209 118 54
IL-12(5) 11 87 46
EL-4(1), IL-7 94 ND 63
IL-4(1), IL-10 95 ND 18
IL-4(1), IL-12 0 ND 14
antiIL-4, IL-7 ND 133 123
antiIL-4, IL-10 ND 279 191
antiIL-4, IL-12 ND 241 138
Cultures containing small T lymphocytes (300,000 cells/well/0.2ml) and equal 
number of influenza virus infected, fixed autologous PBMCs were supplemented with 
cytokines (on day mentioned in parenthesis) or antibodies (at the onset o f culture).
On day 7, cytotoxic activity of the cultures were determined against influenza virus 
infected autologous PBMCs and results expressed as lytic units at 20% lysis for 107 
cells. ND - Not done.
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Table 5.3
IL-7 augments T cell proliferation independent of IL-2.
Cytokines/
Antibodies
Proliferation, CPM
Expt.l, Donor #141 Expt.2, Donor #142
None 353 ± 70.8 435 ± 101.6
IL-2 614 ± 16.0 556 ± 167.1
IL-7 7424 ± 1603.1 2989 ± 543.1
IL-7 + IL-2 9796 ± 1262.6 4207 ± 578.3
IL-7 + antiIL-2 ND 2035 ± 205.9
Cultures consisting of small T  lymphocytes (100,000 cells/well/0.2ml), influenza 
virus infected, fixed autologous PBMCs (10s cell/well/0.2ml) and cytokines (added 
on day 1) and incubated for 4 days. Proliferation assayed as 3H-TdR incorporation 
during the last 20 hours of culture and expressed as counts per minutes ± standard 
deviation. ND - Not done.
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Table 5.4
IL-4 is inhibits IL-7 mediated T cell proliferation.
Cytokines/
Antibodies
Proliferation, CPM
Expt.l, Donor #141 Expt.2, Donor #142
None 354 ± 70.8 435 ± 101.6
IL-4 606 ± 105.1 356 ± 17.1
IL-7 7424 ± 1603.1 2989 ± 543.1
IL-7 + IL-4 6992 ± 1005.1 2429 ± 607.4
IL-7 + antiIL-4 9617 ± 1153.4 3789 ± 548.5
Cultures consisting of small T lymphocytes (105 cells/well/0.2ml), influenza virus 
infected and fixed autologous PBMCs (10s cell/well/0.2ml) and cytokines (added on 
day 1) and incubated for 4 days. Proliferation assayed as 3H-TdR incorporation 
during the last 20 hours of culture and expressed as counts per minutes ± standard 
deviation.
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Table 5.5
The combination of IL-10 or IL-12 with IL-2 or IL-4 augments proliferation.
Proliferation, CPM
Cytokines Donor Number
Added 131 141
None 72 ± 24.5 (1.0) 354 ± 70.8 (1.0)
IL-2 394 ± 50.0 (2.3) 614 ± 16.0 (1.7)
IL-4 486 ± 102.8 (2.8) 606 ± 105.1 (1.7)
IL-10 458 ± 68.7 (2.7) 341 ± 133.7 (1.0)
IL-12 334 ± 55.4 (1.9) 681 ± 85.4 (1.9)
IL-2 + IL-10 920 ± 169.8 (5.3) 1338 ± 185.4 (3.8)
IL-2 + IL-12 580 ± 80.3 (3.4) 2162 ± 588.6 (6.1)
IL-4 + IL-10 783 ± 68.4 (4.6) 1670 ± 393.6 (4.7)
IL-4 + IL-12 432 ± 43.4 (2.5) 1796 ± 368.4 (5.1)
Cultures consisting of small T lymphocytes (105 cells/well/0.2ml), influenza virus 
infected, fixed autologous PBMCs (105 cell/well/0.2ml) and cytokines (added on day 
1) were incubated for 4 days. Proliferation was assayed as 3H-TdR incorporation 
during the last 20 hours of culture and expressed as counts per minutes ± standard 
deviation, with the increase above control in parenthesis.
56
10 nor IL-12 provides a proliferation signal, they nevertheless augment the response 
to IL-2 and IL-4.
Discussion
Previous studies in our laboratory have shown that IL-7, IL-10 and IL-12 are 
potent inducers of influenza virus specific secondary CTL (Chapter 4). Many 
previous reports have demonstrated the requirement for IL-2 and or IL-4 in the 
maturation of cytotoxic cells (Horohov et al., 1988; Quentmeier et al., 1992; 
Bertagnolli et al., 1991; Widmer et al., 1987). In this chapter I have examined the 
role of IL-2 or IL-4 in mCTL induction by IL-7, IL-10 and IL-12.
Various modulatory effects of IL-2 on IL-7, IL-10 and IL-12 mediated 
cytotoxicity have been reported. IL-2 has been reported to have no direct effect on 
IL-7 induced non-specific, redirected cytotoxicity (Smyth et al., 1991) and some role 
in cytotoxicity induction in MLC and lectin stimulated cultures (Alderson et al.,
1990; Bertagnolli, et al., 1990). Chen et al. (1991) reported that IL-2 was required 
for IL-10 induction of CTL activity from Con-A activated murine splenic T-cells, IL- 
10 alone having no effect. IL-12 induction of non-specific LAK activity was reported 
to be independent of IL-2 (Gately et al., 1992), whereas its effect on allogeneic CTL 
was IL-2 dependent (Gately et al., 1986; Gately et al., 1992).
I have shown in Chapter 4 that IL-7, IL-10 and IL-12 can directly augment 
influenza virus specific mCTL generation. Addition of IL-2 to cultures supplemented 
with these cytokines failed to induce elevated levels of cytotoxicity beyond those
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obtained with the cytokines alone. Nor did I find any significant reduction in 
cytokine mediated cytotoxicity following the addition of antiIL-2 antibodies. Taken 
together, these results indicate that IL-7, IL-10 and IL-12 have a direct effect on 
influenza virus specific mCTL induction.
In parallel to the observations on the role of IL-2 in cytotoxicity induction, there 
are also contradictory reports on its role in the proliferative response mediated by 
other cytokines. Morrissey et al. (1989) found a requirement for IL-2 in IL-7 
mediated proliferation, whereas Grabstein et al. (1990) reported both an IL-2 
dependent and independent component in Con-A stimulated, IL-7 mediated 
proliferation of resting murine splenic T cells. Welch et al. (1989) showed that IL-2 
augmented proliferation mediated by a suboptimal dose of IL-7. Chen et al. (1991) 
showed that IL-10 augments proliferation of Con-A stimulated splenic T-cells in an 
IL-2 dependent manner. Similarly IL-10 also augments murine thymocytes 
proliferation in an IL-2 dependent manner (MacNeil et al., 1990; Suda et al., 1990). 
IL-12 was reported to induce proliferation of PHA stimulated (Kobayashi et al.,
1989; W olf et al., 1991; Stem et al., 1990) or phorbol ester stimulated (Kobayashi et 
al., 1989; W olf et al., 1991) peripheral blood lymphocytes. Bertagnolli et al., (1992) 
reported IL-12 mediated proliferation independent of IL-2 when they were stimulated 
with alloantigen or solid phase antiCD3/TCR. Gatley and coworhers (1991) reported 
that IL-12 induced proliferation appears to be independent of IL-2 (Gately, et al.,
1991), although IL-2 augmented proliferation to sub-optimal doses of IL-12.
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I found that addition of IL-2 to IL-7 supplemented cultures resulted in an 
increase in the proliferative response and that the addition of a neutralizing antiIL-2 
antisera reduced, but did not eliminate the response. These results indicated that the 
proliferation induced by IL-7 has both an IL-2 dependent and independent 
component. Whereas neither IL-10 nor IL-12 failed to induce proliferation of the 
antigen stimulated human peripheral blood T cells in our assay system, both could 
augment IL-2 mediated proliferation. Thus it appears that unlike their effect on 
cytotoxicity induction, IL-10 and IL-12 have an indirect effect on T cell proliferation.
IL-4 has been reported to inhibit influenza virus-specific mCTL generation 
(Horohov et al., 1988b). IL-4 can also modulate the effects of other cytokines 
(Wagner et al., 1989; Hsieh et al., 1993). Bertagnolli et al. (1990) reported that 
addition of antiIL-4 to IL-7 stimulated murine thymocyte cultures caused a 100% 
increase in cytotoxicity compared to when IL-7 was used alone. Likewise, influenza 
virus specific cytotoxicity in IL-7 stimulated cultures was also increased when 
antiIL-4 was added. Moreover, the addition of IL-4 to these cultures directly 
inhibited mCTL induction and IL-7 mediated proliferation. Likewise, antiIL-4 
augmented IL-7 induced proliferation under the same conditions. These results are in 
contrast to those of Bertagnolli et al. (1990) who reported an additive effect of IL-4 
on IL-7 mediated proliferation. These authors, however, used murine thymocytes in 
their study which could account for this discrepancy. Other have found similar 
differences in the responses of human and murine cells to IL-4 (Horohov et al., 
1988b). While IL-4 also caused similar inhibition of cytotoxicity mediated by IL-10
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and IL-12, it augmented the proliferative response in the presence of either cytokine 
similar to that seen with IL-2.
Thus I conclude that the effects of IL-2 and IL-4 on IL-7, IL-10 and IL-12 are 
varied. While IL-2 act as a positive regulator of cytotoxicity and proliferation, IL-4 
seems to have both positive and negative effects. The regulatory effect of IL-2 or IL- 
4 depends not only on the type of other cytokines in the culture but also time and 
dose dependent.
Chapter 6 
CONCLUSIONS
During the last two decades, it has become increasingly evident that the 
development and propagation of an immune response to pathogens, other foreign 
antigens, or tumor cells is dependent on the interactions of a diverse group of cell 
types including macrophages, dendritic cells, langerhans cells, T and B lymphocytes, 
natural killer (NK) cells, lymphokine activated killer cells (LAK), neutrophils, and 
eosinophils. It is envisaged that the disease process is due to the breakdown of the 
communication in immune system. A major focus of study in immunology has been 
to elucidate the mechanisms of cell-cell interactions and intercellular communications 
which lead to the generation of an optimal immune response. Proper understanding 
of this process may lead to new approaches for intervening and modifying the 
biological response using the body’s own proteins rather than toxic drugs. In fact this 
approach has already been used in the treatment of some cancers (Rosenberg, 1992).
The immune system uses direct cell-cell contact through surface membrane 
receptors for its specific signaling events. In addition, more than 30 low molecular 
weight (15-75kDa) soluble proteins have been characterized which are produced by 
the immune system for short range communication in an autocrine or paracrine 
fashion. These are called the lymphokines or cytokines. The importance of cytokines 
has come to light recently in the observation that the progression of AIDS is 
correlated with a drift from CMI to humoral immune responses and is probably
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cytokine driven (Clerici et al., 1991). Similar cytokine driven selection of a particular 
arm of the immune system and the associated disease or absence of disease has been 
reported in other models (Bretscher et al., 1992; Romagnani, 1992; Scott, 1993).
Infection with influenza virus generates a protective antibody response which is 
long lasting (McMichael et al., 1981). Because of the surface antigenic variation by 
the influenza virus, the protective antibody response quickly becomes ineffective 
(Kilboume et al., 1973). For this reason, epidemics with influenza virus are frequent 
and account for significant mortality (Taylor and Askonas, 1986). CMI was shown to 
be protective and necessary for recovery from influenza. Because the CMI response 
is generated against the internal viral proteins and these proteins are fairly conserved 
in influenza virus it is argued that mechanisms to augment the CMI response should 
be included in future vaccine strategies. Similar arguments have been raised 
regarding a vaccine against AIDS (Salk et al., 1993).
In this study, I have analyzed eight different cytokines, shown to have at least 
some effect on T cells, for their ability to induce a memory CTL response to 
influenza. The premise is that one or more cytokines which specifically augment the 
mCTL response may be used as an adjuvant or immune modulator in future vaccine 
preparations. It has been reported that mCTLp persist in the peripheral blood for long 
periods of time (Horohov et al., 1988a; Borysiewicz et al., 1988a, 1988b), but are not 
activated to effector cells. Decline in mHTL function with diminished production of 
requisite cytokines for mCTL induction was alleged as the defect in this system.
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Identification of HTL derived cytokines, and ways to stimulate their production are 
imperative in developing strategies to modulate immune responses.
I have identified IL-7, IL-10 and IL-12 as suitable candidate as adjuvants in 
vaccine preparation for augmenting memory CMI response. Similar strategies have 
been proposed, using IFN-y and IL-12 as adjuvants to promote CMI responses in 
AIDS vaccines (Salk et al., 1993). An IL-7 dependent tumor regression in mice, 
using IL-7 secreting cell lines, was recently reported (Aoki et ah, 1989). Also 
promising is IL-7s ability to induce maximum antitumor cytotoxicity from tumor 
infiltrating lymphocytes (TIL) (Lynch et ah, 1991). In vivo effects and anti-tumor 
effects of IL-10 and IL-12 are yet to be determined. Since IL-10 was reported to 
have inhibitory effect on some T cells and macrophage function (Chen et ah, 1991), 
it will be interesting to see its in vivo effect on CTL induction. IL-12 on the other 
hand seems to be very promising in the light of recent observation that it promotes 
generation of a CMI response (Hsieh et ah, 1993).
I have achieved the objective of this study, the identification of signals required 
for mCTL induction. Future work should focus on testing these cytokines in vivo for 
their efficacy in generating a sustained CMI response to influenza. Mouse adapted 
influenza virus (influenza A-PR/8) can be used as the test antigen, and cytokines can 
be introduced in different ways. One approach will be to generate transgeneic mice 
expressing the cytokine gene in air-way epithelium, or peripheral T cells can be 
transfected with a cytokine gene and reintroduced in vivo. Another approach will be 
to prime the mice with low dose influenza virus, low dose apparently stimulates a
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CMI response (Salk et al., 1993), along with cytokine(s) as adjuvant and 
subsequently challenge the mice with a lethal dose of virus. Results from these 
studies can then be extrapolated to human vaccination protocols. Success in 
vaccination against influenza may also be extrapolated to more lethal diseases like 
AIDS (Salk et al., 1993). Since cytokines can be used to augment CMI responses, it 
will be useful not only in prophylactic vaccines but also to treat people already 
having the disease.
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